Entrada Therapeutics
TRDA
TRDA
38 hedge funds and large institutions have $302M invested in Entrada Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
67% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 15
Holders
38
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.04M | |
| 2 | +$1.99M | |
| 3 | +$1.97M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$1.57M |
| 5 |
Millennium Management
New York
|
+$932K |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$4.63M | |
| 3 | -$1.54M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.47M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$925K |